Helmy Eltoukhy - 15 Dec 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Co-Chief Executive Officer, Director
Signature
/s/ John G. Saia, as attorney-in-fact for Helmy Eltoukhy
Issuer symbol
GH
Transactions as of
15 Dec 2025
Net transactions value
-$9,402,220
Form type
4
Filing time
17 Dec 2025, 19:18:50 UTC
Previous filing
02 Oct 2025
Next filing
22 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Eltoukhy Helmy Co-Chief Executive Officer, Director 3100 HANOVER STREET, PALO ALTO /s/ John G. Saia, as attorney-in-fact for Helmy Eltoukhy 17 Dec 2025 0001752968

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Sale $8,713,592 -83,945 -3.9% $103.80 2,053,763 15 Dec 2025 Direct F1
transaction GH Common Stock Sale $688,628 -6,620 -0.32% $104.02 2,047,143 15 Dec 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $103.02 to $104.01. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.020 to $104.055. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.